Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments

Clinical Hemorheology and Microcirculation

Volumn 37, Issue 3, 2007, Pages 269-276

  Yada, Toyotaka ^a   Kaji, Shuichiro ^b   Akasaka, Takashi ^c   Mochizuki, Seiichi ^a   Ogasawara, Yasuo ^a   Tanemoto, Kazuo ^a   Yoshida, Kiyoshi ^a   Kajiya, Fumihiko ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

ADMA; AMI; BH4; NOS; Oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOPTERIN; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROBIOPTERIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE MONONITRITE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE; TETRAHYDROBIOPTERIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS;

ADULT; AGED; ARGININE; BIOPTERIN; CASE-CONTROL STUDIES; DRUG THERAPY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRIC OXIDE; OXIDATIVE STRESS; SUPEROXIDES;

EID: 35648971482     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. P. Vallance, A. Leone, A. Calver, J. Collier and S. Moncada, Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure, Lancet 339 (1992), 572-575.
2. S.M. Bode-Boger, R.H. Boger, S. Kienke, W. Junker and J.C. Frolich, Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits, Biochem. Biophys. Res. Commun. 219 (1996), 598-603.
3. R.H. Boger, S.M. Bode-Boger, W. Thiele, W. Junker, K. Alexander and J.C. Frolich, Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease, Circulation 95 (1997), 2068-2074.
4. D.G. Harrison, Cellular and molecular mechanisms of endothelial cell dysfunction, J. Clin. Invest. 100 (1997), 2153-2157.
5. H. Drexler, Endothelial dysfunction: clinical implications, Prog. Cardiovasc. Dis. 39 (1997), 287-324.
6. A. Ito, P.S. Tsao, S. Adimoolam, M. Kimoto, T. Ogawa and J.P. Cooke, Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase, Circulation 99 (1999), 3092-3095.
7. - imbalance in insulin-resistant rat aorta, Diabetes 48 (1999), 2437-2445.
8. A. Pettersson, L. Uggla and V. Backman, Determination of dimethylated arginines in human plasma by high-performance liquid chromatography, J. Chromatogr. 692 (1997), 257-262.
9. Y. Haruna, Y. Morita, N. Komai, T. Yada, T. Sakuta, N. Tomita, D.A. Fox and N. Kashihara, Endothelial dysfunction in rat adjuvant-induced arthritis: Vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase, Arthritis Rheum. 54 (2006), 1847-1855.
10. S. Mochizuki, P. Sipkema, M. Goto, O. Hiramatsu, H. Nakamoto, E. Toyota, T. Kajita, F. Shigeto, T. Yada, Y. Ogasawara and F. Kajiya, Exogenous NO suppresses flow-induced endothelium-derived NO production because of depletion of tetrahydrobiopterin, Am. J. Physiol. 288 (2005), H553-H558.
11. 15N]nitrate in biological fluids, Anal. Biochem. 126 (1982), 131-138.
12. H. Itabe, E. Takeshima, H. Iwasaki, J. Kimura, Y. Yoshida, T. Imanaka and T. Takano, A monoclonal antibody against oxidizd lipoprotein recognizes foam cells in atherosclerotic lesions, J. Biol. Chem. 269 (1994), 15274-15279.
13. L. Vergnani, S. Hatrik, F. Ricci, A. Passaro, N. Manzoli, G. Zuliani, V. Brovkovych, R. Fellin and T. Malinski, Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: key role of L-arginine availability, Circulation 101 (2000), 1261-1266.
14. R.H. Boger, S.M. Bode-Boger, P.S. Tsao, P.S. Lin, J.R. Chan and J.P. Cooke, An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes, J. Am. Coll. Cardiol. 36 (2000), 2287-2295.
15. J.R. Chan, R.H. Boger, S.M. Bode-Boger, O. Tangphao, P.S. Tsao, T.F. Blaschke and J.P. Cooke, Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans, Arterioscler. Thromb. Vasc. Biol. 20 (2000), 1040-1046.
16. - imbalance in insulin-resistant rat aorta, Diabetes 48 (1999), 2437-2445.
17. K. Shinozaki, Y. Nishio, T. Okamura, Y. Yoshida, H. Maegawa, H. Kojima, M. Masada, N. Toda, R. Kikkawa and A. Kashiwagi, Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats, Circ. Res. 87 (2000), 566-573.
18. A. Ito, K. Egashira, T. Narishige, K. Muramatsu and A. Takeshita, Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension, Jpn. Circ. J. 65 (2001), 775-778.
19. S.M. Bode-Boger, J. Martens-Lobenhoffer, M. Tager, H. Schroder and F. Scalera, Aspirin reduces endothelial cell senescence, Biochem. Biophys. Res. Commun. 334 (2005), 1226-1232.
20. H.M. Eid, J. Eritsland, J. Larsen, H. Arnesen and I. Seljeflot, Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin, Atherosclerosis 166 (2003), 279-284.
21. E.M. de Cavanagh, C.G. Fraga, L. Ferder and F. Inserra, Enalapril and captopril enhance antioxidant defenses in mouse tissues, Am. J. Physiol. 272 (1997), R514-R518.
22. T. Yada, M. Goto, O. Hiramatsu, H. Tachibana, E. Toyota, H. Nakamoto, Y. Ogasawara, H. Matsuda, K. Arakawa, K. Hayashi, H. Suzuki and F. Kajiya, In vivo visualization of subendocardial arteriolar response in renovascular hypertensive hearts, Am. J. Physiol. 284 (2003), H1785-H1792.
23. H. Shimokawa, Primary endothelial dysfunction: Atherosclerosis, J. Mol. Cell. Cardiol. 31 (1999), 23-37.
24. T. Yada, H. Shimokawa and F. Kajiya, Cardioprotective effect of hydroxyfasudil as a specific Rho-kinase inhibitor, on ischemia-reperfusion injury in canine coronary microvessels in vivo, Clin. Hemorheol. Microcirc. 34 (2006), 177-183.
25. H.J. Hong, G. Hsiao, T.H. Cheng and M.H. Yen, Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats, Hypertension 38 (2001), 1044-1048.
26. S. Verma, F. Lovren, A.S. Dumont, K.J. Mather, A. Maitland, T.M. Kieser, C.R. Triggle and T.J. Anderson, Tetrahydrobiopterin improves endothelial function in human saphenous veins, J. Thorac. Cardiovasc. Surg. 120 (2000), 668-671.